These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
483 related items for PubMed ID: 21313813
1. Development and validation of a high-performance liquid chromatographic method for determination of eprosartan in bulk drug and tablets. Patel HU, Suhagia BN, Patel CN. J AOAC Int; 2010; 93(6):1862-7. PubMed ID: 21313813 [Abstract] [Full Text] [Related]
2. Development and validation of a stability-indicating column high-performance liquid chromatographic assay method for determination of nebivolol in tablet formulation. Kachhadia PK, Doshi AS, Joshi HS. J AOAC Int; 2008; 91(3):557-61. PubMed ID: 18567301 [Abstract] [Full Text] [Related]
3. Determination of eprosartan mesylate and hydrochlorothiazide in tablets by derivative spectrophotometric and high-performance liquid chromatographic methods. Hacioğlu F, Onal A. J Chromatogr Sci; 2012 Sep; 50(8):688-93. PubMed ID: 22576732 [Abstract] [Full Text] [Related]
4. Simultaneous analysis of eprosartan and hydrochlorothiazide in tablets by high-performance liquid chromatography. Patel HU, Suhagia BN, Patel CN. Pharm Methods; 2011 Apr; 2(2):143-7. PubMed ID: 23781445 [Abstract] [Full Text] [Related]
5. Identification and determination of selected angiotensin II receptor antagonist group drugs by HPLC method. Czerwińska K, Mazurek AP. Acta Pol Pharm; 2011 Apr; 68(6):831-7. PubMed ID: 22125946 [Abstract] [Full Text] [Related]
6. Spectral and polarographic determination of eprosartan. Kinetic studies of the oxidation of eprosartan using a platinum electrode. El-Yazbi FA, Hammud HH, Sonji NM, Sonji GM. Pharmazie; 2008 Jun; 63(6):420-7. PubMed ID: 18604984 [Abstract] [Full Text] [Related]
7. A selective high-performance liquid chromatography method for the determination of reboxetine in bulk drug and tablets. Onal A, Sağiri O, Cetin SM, Toker S. J AOAC Int; 2006 Jun; 89(6):1552-6. PubMed ID: 17225601 [Abstract] [Full Text] [Related]
8. Development and validation of a stability-indicating HPLC assay method for simultaneous determination of spironolactone and furosemide in tablet formulation. Ram VR, Dave PN, Joshi HS. J Chromatogr Sci; 2012 Sep; 50(8):721-6. PubMed ID: 22641089 [Abstract] [Full Text] [Related]
9. Stability-indicating RP-HPLC method development and validation for duloxetine hydrochloride in tablets. Patel SK, Patel NJ, Prajapati AM, Patel DB, Patel SA. J AOAC Int; 2010 Sep; 93(1):123-32. PubMed ID: 20334174 [Abstract] [Full Text] [Related]
10. Stress degradation studies and kinetic determinations of duloxetine enteric-coated pellets by HPLC. Gomes P, Wingert NR, Paim CS, Schapoval EE, Steppe M. J AOAC Int; 2010 Sep; 93(6):1829-35. PubMed ID: 21313809 [Abstract] [Full Text] [Related]
11. A stability-indicating high performance liquid chromatographic (HPLC) assay for the simultaneous determination of atorvastatin and amlodipine in commercial tablets. Mohammadi A, Rezanour N, Ansari Dogaheh M, Ghorbani Bidkorbeh F, Hashem M, Walker RB. J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Feb 01; 846(1-2):215-21. PubMed ID: 17010681 [Abstract] [Full Text] [Related]
12. Quality by design: a systematic and rapid liquid chromatography and mass spectrometry method for eprosartan mesylate and its related impurities using a superficially porous particle column. Kalariya PD, Kumar Talluri MV, Gaitonde VD, Devrukhakar PS, Srinivas R. J Sep Sci; 2014 Aug 01; 37(16):2160-71. PubMed ID: 24913516 [Abstract] [Full Text] [Related]
13. Liquid chromatographic determination of cetirizine in oral formulations. Bajerski L, Cardoso SG, Diefenbach IF, Malesuik MD, Sílvia H, Borgmann M. J AOAC Int; 2005 Aug 01; 88(2):424-7. PubMed ID: 15859066 [Abstract] [Full Text] [Related]
14. Development and validation of a HPLC-UV method for the determination in didanosine tablets. de Oliveira AM, Löwen TC, Cabral LM, dos Santos EM, Rodrigues CR, Castro HC, dos Santos TC. J Pharm Biomed Anal; 2005 Jul 15; 38(4):751-6. PubMed ID: 15967304 [Abstract] [Full Text] [Related]
15. Development and validation of a new HPLC-UV method for the simultaneous determination of triclabendazole and ivermectin B1a in a pharmaceutical formulation. Shurbaji M, Abu Al Rub MH, Saket MM, Qaisi AM, Salim ML, Abu-Nameh ES. J AOAC Int; 2010 Jul 15; 93(6):1868-73. PubMed ID: 21313814 [Abstract] [Full Text] [Related]
16. Validated stability-indicating assay method for simultaneous determination of aceclofenac and thiocolchicoside using RP-HPLC. Samanthula G, Shrigod VV, Patel PN. Drug Res (Stuttg); 2014 Aug 15; 64(8):429-35. PubMed ID: 24310363 [Abstract] [Full Text] [Related]
17. Validated stability-indicating HPLC-DAD method for determination of the recently approved hepatitis C antiviral agent daclatasvir. Baker MM, El-Kafrawy DS, Mahrous MS, Belal TS. Ann Pharm Fr; 2017 May 15; 75(3):176-184. PubMed ID: 28187879 [Abstract] [Full Text] [Related]
18. Determination of olmesartan medoxomil in tablets by UV-Vis spectrophotometry. Celebier M, Altinoz S. Pharmazie; 2007 Jun 15; 62(6):419-22. PubMed ID: 17663188 [Abstract] [Full Text] [Related]
19. Liquid chromatographic method for the simultaneous determination of eprosartan and hydrochlorothiazide in tablets and human plasma. Belal F, El-Brashy AM, El-Enany N, Tolba MM. J AOAC Int; 2011 Jun 15; 94(3):823-32. PubMed ID: 21797010 [Abstract] [Full Text] [Related]
20. Validation of a solid phase extraction-high performance liquid chromatographic method for the determination of eprosartan in human plasma. Ferreirós N, Iriarte G, Alonso RM, Jiménez RM, Ortíz E. J Chromatogr A; 2006 Jun 30; 1119(1-2):309-14. PubMed ID: 16542666 [Abstract] [Full Text] [Related] Page: [Next] [New Search]